OBJECTIVES: Erythroid differentiation is a dynamic process in which a pluripotent stem cell undergoes a series of developmental changes that commit it to a specific lineage. These alterations involve changes in gene expression profiles. In this study, gene expression profiles during differentiation of human erythroid cells of a normal blood donor were evaluated using SAGE. MATERIALS AND METHODS: Global gene expression was evaluated in cells collected immediately before addition of erythropoietin (0 h) and 192 and 336 h after addition of this hormone. Real-time PCR was used to evaluate activation of differentially expressed genes. RESULTS: The data indicate that global aspects of the transcriptome were similar during differentiation of the majority of the genes and that a relatively small set of genes is probably involved in modification of erythroid cells during differentiation. We have identified 93 differentially expressed genes during erythroid development, and expression of some of these was confirmed by qPCR. Various genes including EYA3, ERH, HES6, TIMELESS and TRIB3 were found to be homologous to those of Drosophila melanogaster and here are described for the first time during erythroid development. An important and unique carboxypeptidase inhibitor described in mammalians, LXN, was also identified. CONCLUSIONS: The results of this study amplify previously published data and may contribute to comprehension of erythroid differentiation and identification of new target genes involved in some erythroid concerning diseases.
OBJECTIVES: Erythroid differentiation is a dynamic process in which a pluripotent stem cell undergoes a series of developmental changes that commit it to a specific lineage. These alterations involve changes in gene expression profiles. In this study, gene expression profiles during differentiation of human erythroid cells of a normal blood donor were evaluated using SAGE. MATERIALS AND METHODS: Global gene expression was evaluated in cells collected immediately before addition of erythropoietin (0 h) and 192 and 336 h after addition of this hormone. Real-time PCR was used to evaluate activation of differentially expressed genes. RESULTS: The data indicate that global aspects of the transcriptome were similar during differentiation of the majority of the genes and that a relatively small set of genes is probably involved in modification of erythroid cells during differentiation. We have identified 93 differentially expressed genes during erythroid development, and expression of some of these was confirmed by qPCR. Various genes including EYA3, ERH, HES6, TIMELESS and TRIB3 were found to be homologous to those of Drosophila melanogaster and here are described for the first time during erythroid development. An important and unique carboxypeptidase inhibitor described in mammalians, LXN, was also identified. CONCLUSIONS: The results of this study amplify previously published data and may contribute to comprehension of erythroid differentiation and identification of new target genes involved in some erythroid concerning diseases.
Authors: Michel de Chaldée; Marie-Claude Gaillard; Nicolas Bizat; Jean-Marie Buhler; Olivier Manzoni; Joël Bockaert; Philippe Hantraye; Emmanuel Brouillet; Jean-Marc Elalouf Journal: Genome Res Date: 2003-07 Impact factor: 9.043
Authors: A Naderi; A E Teschendorff; N L Barbosa-Morais; S E Pinder; A R Green; D G Powe; J F R Robertson; S Aparicio; I O Ellis; J D Brenton; C Caldas Journal: Oncogene Date: 2006-08-28 Impact factor: 9.867
Authors: Martina Komor; Saskia Güller; Claudia D Baldus; Sven de Vos; Dieter Hoelzer; Oliver G Ottmann; Wolf-K Hofmann Journal: Stem Cells Date: 2005-06-13 Impact factor: 6.277
Authors: S Tozlu-Kara; V Roux; C Andrieu; J Vendrell; S Vacher; V Lazar; F Spyratos; M Tubiana-Hulin; P Cohen; P Dessen; R Lidereau; I Bièche Journal: J Mol Endocrinol Date: 2007-10 Impact factor: 5.098
Authors: Kun Pang; Mei-Li Li; Lin Hao; Zhen-Duo Shi; Harry Feng; Bo Chen; Yu-Yang Ma; Hao Xu; Deng Pan; Zhe-Sheng Chen; Cong-Hui Han Journal: Front Oncol Date: 2022-05-23 Impact factor: 5.738
Authors: Karen S Romanello; Karina K L Teixeira; João Pedro M O Silva; Sheila T Nagamatsu; Marcos André C Bezerra; Igor F Domingos; Diego A P Martins; Aderson S Araujo; Carolina Lanaro; Carlos A Breyer; Regiane A Ferreira; Carla Franco-Penteado; Fernando F Costa; Iran Malavazi; Luis E S Netto; Marcos A de Oliveira; Anderson F Cunha Journal: PLoS One Date: 2018-12-06 Impact factor: 3.240
Authors: S Machherndl-Spandl; S Suessner; M Danzer; J Proell; C Gabriel; J Lauf; R Sylie; H-U Klein; M C Béné; A Weltermann; P Bettelheim Journal: Blood Cancer J Date: 2013-01-11 Impact factor: 11.037
Authors: Heba A Alkhatabi; Donal P McLornan; Austin G Kulasekararaj; Farooq Malik; Thomas Seidl; David Darling; Joop Gaken; Ghulam J Mufti Journal: Oncotarget Date: 2016-07-26